Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Vital Signs, Inc.

This article was originally published in The Gray Sheet

Executive Summary

Respiratory device maker investigates allegations of accounting improprieties asserted by former CFO Joseph Bourgart in a May 7 complaint filed in New Jersey Superior Court. Totowa, N.J.-based Vital Signs "vigorously denies" the allegations, and maintains that Bourgart is a "disgruntled" employee who was forced to resign in January "after being confronted with evidence that he anonymously forwarded confidential corporate information to an investor." On May 8, the firm reported flat fiscal second-quarter sales of $42.1 mil.; sales for the quarter (ended March 31) excluded $3.3 mil. due to an adjustment to the "allowance for rebates" to distributors following a recent review of the practice...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT018381

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel